Tags » Gleevec

Novartis's Q3 2016 net income $10,9B shorter than last year

Novartis has reported net income of $5.8 billion compared to $16.7 billion in the prior-year period.

Basic earnings per share decreased to $2.42 from $6.94. 113 more words


24th Month into Glivec

2 years into Glivec. We are optimistic and thank God for the blessings we received to see Dad doing well. On the last CT Scan we did not see any change to the size of the tumour. 431 more words

Dad's Health Journal

What a "game-changing" cancer therapy really looks like

A 55-year-old diagnosed with chronic myeloid leukemia in 1990 could expect to lose more than 20 years of life as a result of the cancer. By 2010, the loss in expectation of life was… 394 more words
Health & Medicine

Live Notes from @AACR’s #cbi16 Meeting on Precision Medicine: 3:45PM Big Idea Dr. Hait and Premalignancy

 Live Notes from @AACR’s #cbi16 Meeting on Precision Medicine: 3:45PM Big Idea Dr. Hait and Premalignancy

Big Idea: Interception: Search for therapies that can tackle pre-malignancies to prevent cancer by Dr. 95 more words

India's Sun Pharmaceutical enters $2.5B US market with its generic version of Gleevec

Sun Pharmaceutical Industries, largest India-based generic pharmaceutical companies, has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Novartis’ Gleevec. 69 more words


Smoking out Leukemia Cells to Prevent Cancer Relapse

Ninety-five percent of all patients with chronic myeloid leukemia (CML), carry a Frankenstein-like gene, called BCR-ABL, created from an abnormal fusion of two genes normally found on two separate chromosomes. 714 more words


The Most Critical Factor in Medicine? Human Bias

Oncologist and writer Siddhartha Mukherjee suggests that what doctors fight against isn’t so much disease — it’s their own biases.

In the summer of 2003, I finished my three-year residency in internal medicine and began a fellowship in oncology. 408 more words